[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-339071-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-339071-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","association-oftet-methylcytosine-dioxygenase-2-and-5-hydroxymethylcytosine-in-endometrioid-adenocarcinoma-and-its-clinical-significance","Association oftet methylcytosine dioxygenase 2 and 5-hydroxymethylcytosine in endometrioid adenocarcinoma and its clinical significance","","Aberrant DNA methylation is a key molecular alteration in type I endometrial cancers, while TET2 and 5-hydroxymethylcytosine (5hmC) are central to DNA demethylation. This study examined the clinical significance of co-expressed TET2 and 5hmC in endometrial cancer. TET2 and 5hmC levels were measured in 326 tissues by immunohistochemistry, correlations and prognostic effects were assessed using Pearson, Kaplan–Meier, and Cox models.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/association-oftet-methylcytosine-dioxygenase-2-and-5-hydroxymethylcytosine-in-endometrioid-adenocarcinoma-and-its-clinical-significance/339071/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/association-oftet-methylcytosine-dioxygenase-2-and-5-hydroxymethylcytosine-in-endometrioid-adenocarcinoma-and-its-clinical-significance/339071.png","ImageObject",300,407,{"name":42,"@type":43},"Lucas Martin","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",5,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What molecular factors were investigated in endometrioid adenocarcinoma?","Question",{"text":63,"@type":64},"The study focused on TET2 and 5-hydroxymethylcytosine (5hmC), which are involved in DNA demethylation. It specifically assessed their co-expression in endometrial cancer.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were TET2 and 5hmC levels measured?",{"text":68,"@type":64},"TET2 and 5hmC levels were detected in 326 endometrial tissue samples using immunohistochemistry. Correlation between their levels was evaluated using Pearson analysis.",{"name":70,"@type":61,"acceptedAnswer":71},"What did the results show about the relationship between TET2 and 5hmC?",{"text":72,"@type":64},"TET2 protein level was positively correlated with 5hmC level in endometrial cancer tissues (r=0.801, P\u003C0.001). The combined high TET2 and high 5hmC group was linked to specific clinicopathologic features and prognostic outcomes.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},339071,1790892706,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,100,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Comic",60,"comic",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},6,"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":55,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":115,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},8796095360427,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","Kuang et al. BMC Women’s Health (2024) 24:188 [https://doi.org/10.1186/s12905-024-03021-2](https://doi.org/10.1186/s12905-024-03021-2)  \nBMC Women’s Health  \n RESEARCH Open Access  \nAssociation oftet methylcytosine  \ndioxygenase 2 and 5-hydroxymethylcytosine in endometrioid adenocarcinoma and its clinical significance  \nLei Kuang1†, Jingbo Zhang1†, Yanyu Li1, Qing Wang1, Jianwei Liu1 and Bei Zhang1*  \nAbstract  \nBackground Aberrant DNA methylation is a vital molecular alteration commonly detected in type I endometrial cancers (EC), and tet methylcytosine dioxygenase 2 (TET2) and 5-hydroxymethylcytosine (5hmC) play significant roles in DNA demethylation. However, little is known about the function and correlation ofTET2 and 5hmC co-expressed in EC. This study intended to investigate the clinical significance ofTET2 and 5hmC in EC.  \nMethods The levels ofTET2 and 5hmC were detected in 326 endometrial tissues by immumohistochemistry, and the correlation of their level was detected by Pearson analysis. The association between the levels ofTET2 and 5hmC and clinicopathologic characteristics was analyzed. Prognostic value ofTET2 and 5hmC was explored by Kaplan–Meier analysis. The Cox proportional hazard regression model was used for univariate and multivariate analyses.  \nResults Based on the analysis results, TET2 protein level was positively correlated with 5hmC level in EC tissues (r= 0 . 801, P \u003C 0. 001) . TET2+5hmC+ (highTET2 and high 5hmC) association was significantly associated with well differentiation, myometrial invasion, negative lymph node metastasis, and tumor stage in EC. Association ofTET2 and 5hmC was confirmed as a prognostic factor (HR = 2 . 843, 95%CI = 1 .226–3. 605, P = 0 . 007) for EC patients, and EC patients with TET2 − 5hmC − level had poor overall survival.  \nConclusions In summary, the association ofTET2 and 5hmC was downregulated in EC tissues, and may be a potential poor prognostic indicator for EC patients. Combined detection ofTET2 and 5hmC may be valuable for the diagnosis and prognosis of EC.  \nKeywords Endometrial cancer, Tet methylcytosine dioxygenase 2, 5-hydroxymethylcytosine, Association, Prognosis  \n†Lei Kuang and Jingbo Zhang contributed equally to this work as Co-first author.  \n*Correspondence: Bei Zhang [bettyzhang10@163.com](bettyzhang10@163.com)  \n1 Department of Obstetrics and Gynecology, Xuzhou Central Hospital, Xuzhou Clinical School of Xuzhou Medical University, No. 199 South Jiefang Road, Xuzhou 221009, China  \nIntroduction  \nEndometrial cancer (EC) is one of the most prevalent gynecological cancers, which accounts for 20%–30% of female genital malignancies and 7% of female systemic malignancies [1]. In recent years, the incidence of EC in China has increased year by year, and the age of onset is getting younger and younger [2]. Although early diagnosis results in a good overall prognosis for most EC patients, 15%-20% of EC patients still experience  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by/4.0/](http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ()[. The Creative Commons Public Domain Dedication waiver (](http://creativecom","cbCaivFfepIpDTMM","https://ap.wps.com/l/cbCaivFfepIpDTMM","pdf",1493759,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Introduction","[{\"question\":\"What molecular factors were investigated in endometrioid adenocarcinoma?\",\"answer\":\"The study focused on TET2 and 5-hydroxymethylcytosine (5hmC), which are involved in DNA demethylation. It specifically assessed their co-expression in endometrial cancer.\"},{\"question\":\"How were TET2 and 5hmC levels measured?\",\"answer\":\"TET2 and 5hmC levels were detected in 326 endometrial tissue samples using immunohistochemistry. Correlation between their levels was evaluated using Pearson analysis.\"},{\"question\":\"What did the results show about the relationship between TET2 and 5hmC?\",\"answer\":\"TET2 protein level was positively correlated with 5hmC level in endometrial cancer tissues (r=0.801, P\\u003c0.001). The combined high TET2 and high 5hmC group was linked to specific clinicopathologic features and prognostic outcomes.\"}]","Association oftet methylcytosine dioxygenase 2 and 5-hydroxymethylcytosine in endometrioid adenocarcinoma and its clinical significance | PDF",1790027696,23,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9bcf1ff4801cccf7cf477d261195ed0e.webp",983,1305,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cb88cdfa383ee7c91f8be0387cf4832e.webp",982,1304,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c124fc3be87e663b0fe473eaf49ea83d.webp",981,1303,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ed370721c072f5908d422edd41ea7637.webp",980,1301]